Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 2
2004 1
2005 2
2006 2
2008 1
2010 1
2011 1
2012 3
2013 1
2014 2
2015 1
2016 1
2017 3
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Development of Gs-selective inhibitory compounds.
Nanoff C, Kudlacek O, Freissmuth M. Nanoff C, et al. Methods Enzymol. 2002;344:469-80. doi: 10.1016/s0076-6879(02)44734-9. Methods Enzymol. 2002. PMID: 11771404 No abstract available.
The value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.
Li S, Peck-Radosavljevic M, Ubl P, Wadsak W, Mitterhauser M, Rainer E, Pinter M, Wang H, Nanoff C, Kaczirek K, Haug A, Hacker M. Li S, et al. Among authors: nanoff c. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1732-1741. doi: 10.1007/s00259-017-3724-2. Epub 2017 May 29. Eur J Nucl Med Mol Imaging. 2017. PMID: 28555333 Free PMC article.
Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor.
Bergmayr C, Thurner P, Keuerleber S, Kudlacek O, Nanoff C, Freissmuth M, Gruber CW. Bergmayr C, et al. Among authors: nanoff c. J Biol Chem. 2013 Oct 4;288(40):28831-44. doi: 10.1074/jbc.M113.464776. Epub 2013 Aug 21. J Biol Chem. 2013. PMID: 23965991 Free PMC article.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page